BioLife Solutions, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BioLife Solutions, Inc. (BLFS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 26.58 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- BioLife Solutions, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 26.58K shares, a 96.22% decline year-over-year.
- BioLife Solutions, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 17.30K shares, a 26.53% decline year-over-year.
- BioLife Solutions, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 67.71K shares, a 94.98% decline year-over-year.
- BioLife Solutions, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 702.93K shares, a 33.82% decline year-over-year.
- BioLife Solutions, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 891.26K shares, a 30.58% decline from fiscal 2024.
- BioLife Solutions, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.28M shares, a 98.33% increase from fiscal 2023.
- BioLife Solutions, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 647.35K shares.
- BioLife Solutions, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 26.58K shares 10-Q · filed 2026-08-06 | 12.12K shares 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | 17.30K shares 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | 891.26K shares 10-K · filed 2026-02-26 | |||||||
| 2025-09-30 | 67.71K shares 10-Q · filed 2025-11-06 | 887.50K shares 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | 702.93K shares 10-Q · filed 2026-08-06 | 944.46K shares 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | 23.55K shares 10-Q · filed 2026-05-07 | 1.23M shares 10-Q · filed 2025-05-08 | ||||||
| 2024-12-31 | 1.28M shares 10-K · filed 2026-02-26 | |||||||
| 2024-09-30 | 1.35M shares 10-Q · filed 2025-11-06 | 3.94M shares 10-Q · filed 2024-11-12 | 1.16M shares 10-Q · filed 2025-11-06 | 3.77M shares 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | 1.06M shares 10-Q · filed 2025-08-07 | 3.59M shares 10-Q · filed 2024-08-09 | 1.08M shares 10-Q · filed 2025-08-07 | 3.68M shares 10-Q · filed 2024-08-09 | ||||
| 2024-03-31 | 1.07M shares 10-Q · filed 2025-05-08 | 3.77M shares 10-Q · filed 2024-05-10 | ||||||
| 2023-12-31 | 647.35K shares 10-K · filed 2026-02-26 | |||||||
| 2023-09-30 | 2.64M shares 10-Q · filed 2024-11-12 | 3.01M shares 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | 3.03M shares 10-Q · filed 2024-08-09 | 3.20M shares 10-Q · filed 2024-08-09 | ||||||
| 2023-03-31 | 3.15M shares 10-Q · filed 2024-05-10 | |||||||
| 2022-12-31 | 0.00 shares 10-K · filed 2025-03-03 | 1.66M shares 10-K · filed 2023-03-31 | ||||||
| 2022-09-30 | 2.02M shares 10-Q · filed 2023-11-09 | 2.68M shares 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | 1.94M shares 10-Q · filed 2023-08-09 | 2.77M shares 10-Q · filed 2023-08-09 | ||||||
| 2022-03-31 | 2.09M shares 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | 1.66M shares 10-K · filed 2024-02-29 | |||||||
| 2021-09-30 | 0.00 shares 10-Q · filed 2022-11-09 | 0.00 shares 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | 0.00 shares 10-Q · filed 2022-08-09 | 0.00 shares 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | 2.21M shares 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | 3.63M shares 10-K · filed 2022-03-31 | |||||||
| 2020-09-30 | 2.25M shares 10-Q · filed 2021-11-15 | 0.00 shares 10-Q · filed 2021-11-15 | ||||||
| 2020-06-30 | 3.85M shares 10-Q · filed 2021-08-16 | 0.00 shares 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | 5.52M shares 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | 5.52M shares 10-K · filed 2022-03-31 | |||||||
| 2018-12-31 | 5.37M shares 10-K · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |